Synergistic therapeutic efficacy and safety of anlotinib and sequential radiotherapy in advanced central squamous-cell lung cancer
Saved in:
Main Authors: | Nan Wei, Xuan Wu, Xiaoju Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Asian Journal of Surgery |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958424019882 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination of Cemiplimab and Radiotherapy in Advanced Squamous Cell Carcinoma
by: André Aparício Martins, et al.
Published: (2025-01-01) -
Synergistic Antitumor Effects of Anlotinib Combined with Oral 5-Fluorouracil/S-1 via Inhibiting Src/AKT Signaling Pathway in Small-Cell Lung Cancer
by: Xinhang Xia, et al.
Published: (2022-01-01) -
Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy
by: Robert M. Samstein, et al.
Published: (2014-01-01) -
Dramatic response of advanced pulmonary sarcomatoid carcinoma to tislelizumab combined with anlotinib: a case report
by: Ranran Li, et al.
Published: (2025-02-01) -
Anlotinib as Maintenance Therapy After First-Line Chemotherapy Combined with Consolidation Radiation for Extensive-Stage Small Cell Lung Cancer
by: Jinbo Ma MD, et al.
Published: (2025-01-01)